LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
LLY
795.48
+0.43%↑
JNJ
152.14
-0.14%↓
ABBV
186.94
+0.72%↑
NVO
67.74
+0.61%↑
UNH
302.46
+0.12%↑
24h
Current
Min
10.46
Max
10.77
Past performance is not a reliable indicator of future results.
19 Dec 2024, 00:26 UTC
Mesoblast ADRs Rise 22%, FDA Approves Ryoncil for Pediatric Patients -- Update
DJ
Read
Price change
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Based on 0 analysts giving stock ratings to Mesoblast Ltd ADR - Dist in the past 3 months.
$